A Safer Dementia-Related Psychosis Treatment Grows Closer to FDA Approval
Phase III trials for experimental dementia-related psychosis treatment pimavanserin draw interest at AAIC; FDA begins consideration of the drug approval. As many as half…
Phase III trials for experimental dementia-related psychosis treatment pimavanserin draw interest at AAIC; FDA begins consideration of the drug approval. As many as half…
A survey of all drugs currently in clinical trials for Alzheimer’s disease found 121 unique therapies being tested in 136 Alzheimer’s drug trials. That…
Alzheimer’s clinical trials may take decades, but a new discovery could cut clinical trial time down to a matter of weeks. For nearly a century,…
Well, I won’t try that again. Last week, I found myself bent over a table, resting my head on pillows as a doctor injected…
“We are looking for older volunteers with MCI or mild dementia due to AD or Lewy body dementia, and healthy older individuals, who wish…
The response was disappointing but not particularly surprising. Earlier in the day, I had sent a quick email to check in with the staff…
The world of developing drugs to fight beta-amyloid has been on a rollercoaster ride the last year, but some scientists aren’t giving up. Researchers…